This inventor holds 4 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents. Top assignee: Genome and Company. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Areum Jeong: Innovator in Cancer Treatment
Introduction
Areum Jeong is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on enhancing immune responses to combat cancer effectively.
Latest Patents
Areum Jeong holds a patent for a pharmaceutical composition aimed at preventing or treating cancer. This composition includes an LRIT2 inhibitor as its active ingredient. The invention is designed to increase the activity of immune cells, serving as an immune enhancer. By enhancing an individual's immunity, the LRIT2 inhibitor can effectively prevent or treat cancer.
Career Highlights
Areum Jeong is associated with Genome and Company, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is pivotal in advancing cancer treatment methodologies.
Collaborations
Areum collaborates with talented individuals in his field, including Kyoung Wan Yoon and Youn Kyung Houh. Their combined expertise contributes to the innovative projects at Genome and Company.
Conclusion
Areum Jeong's contributions to cancer treatment through his patented inventions highlight his role as a leading inventor in the pharmaceutical industry. His work not only enhances immune responses but also offers hope for effective cancer prevention and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile